Natera paid its 5 named executives $42.1M in total in FY2025 (Dec). CEO Steven Chapman was paid $15.0M of that.
Pay$100 in the stock at the end of FY20 → $230
Pay of each named executive
Steven ChapmanChief Executive Officer and President
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
5 years
Matthew RabinowitzExecutive Chairman
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
5 years
Michael BrophyChief Financial Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
5 years
Solomon MoshkevichPresident, Clinical Diagnostics
| FY2025 (Dec) | |||||||
| FY2024 (Dec) |
2 years
John FeskoPresident, Chief Business Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) |
2 years
CEO pay against the pay peers
In FY2023 (Dec), the median CEO pay of the 1 peer with pay on file was $7.8M. The CEO of Natera was paid $12.7M, 64% above the median.
- 1NateraThis company
- 2Qualys
- 310x Genomics, Inc.Not disclosed
- 4Abiomed, Inc.Not disclosed
- 5BIO-TECHNENot disclosed
- 6CareDx, Inc.Not disclosed
- 7Exact Sciences CorporationNot disclosed
- 8Exelixis, Inc.Not disclosed
- 9Glaukos CorporationNot disclosed
- 10Guardant Health, Inc.Not disclosed
- 11Ionis Pharmaceuticals, Inc.Not disclosed
- 12Masimo CorporationNot disclosed
- 13Myriad Genetics, Inc.Not disclosed
- 14NeoGenomics, Inc.Not disclosed
- 15Neurocrine Biosciences, Inc.Not disclosed
- 16Nevro Corp.Not disclosed
- 17New Relic, Inc.Not disclosed
- 18NovoCure Ltd.Not disclosed
- 19PTC Therapeutics, Inc.Not disclosed
- 20Penumbra, Inc.Not disclosed
- 21Quidel CorporationNot disclosed
- 22Repligen CorporationNot disclosed
- 23Ultragenyx Pharmaceutical, Inc.Not disclosed
- 24Veracyte, Inc.Not disclosed
- 25iRhythm Technologies, Inc.Not disclosed
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.